Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J9223 is classified under Chemotherapy Drugs.
| Key Fact | Detail |
|---|---|
| Service Type | Chemotherapy Drugs |
| Common Place of Service | 11Office 19Off Campus Outpatient Hospital |
| Hospital Outpatient Group (APC) | APC 9389 - Inj. lurbinectedin, 0.1 mg |
| Surgery Center Payment (ASC) | K2 - Drug paid separately with a covered surgery, at the OPPS rate |
| Common Revenue Codes | 06360250 |
| Medicare Fee Schedule | $215.72 per 0.1 mg (October 2026 ASP)View Medicare rates for J9223 |
| Medicaid Fee Schedule | $210.515 median of the 8 states in the free previewView Medicaid rates for J9223 |
| Medicare Payment Limit | |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 68727071201 - ZEPZELCA (Lurbinectedin) 0.5 mg/mL, injection, powder, lyophilized, for solution |
National average reimbursement for HCPCS J9223 by major payers:

$217.35
BCBS / Anthem

$218.22
UnitedHealthcare

$220.64
Aetna

$215.63
Cigna
Choose a payer to see a sample of rates for HCPCS J9223.
The Cooper Health System
Cooper Health System A New Jersey Non-Profit Corporation
Shuk Ki Ku
Chca Bayshore Lp, Bayshore Medical Center
Chattanooga Hamilton County Hospital Authority, Erlanger Medical Center
Erlanger Medical Center
Shore Health System, Inc, Um Shore Medical Center At Easton
Shore Health System Inc
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J9223 vs. Other Chemotherapy Drugs Codes
The table lists codes related to J9223. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 68727071201-NDC | ZEPZELCA (Lurbinectedin) 0.5 mg/mL, injection, powder, lyophilized, for solution |
| J9219-HCPCS | Leuprolide acetate implant, 65 mg |
| J9223-HCPCS | Injection, lurbinectedin, 0.1 mg |
| J9225-HCPCS | Histrelin implant (Vantas), 50 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J9223. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J9223 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J9223) and we'll show you how you compare in 15 minutes or less.
Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J9223 to APC 9389 (Inj. lurbinectedin, 0.1 mg). An APC groups outpatient services that Medicare pays at the same base rate.
CMS lists HCPCS J9223 with ASC payment indicator K2: Drug paid separately with a covered surgery, at the OPPS rate.
Hospital price transparency files list HCPCS J9223 under these revenue codes: 0636 and 0250. A revenue code names the hospital department or charge category for the line; it does not change what the service is.